Gamida Cell News - GMDA

Company Name	Stock Ticker Symbol	Market	Type
Gamida Cell Ltd	GMDA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.0327	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
			0.0327	0.0327

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/08/2024	07:30	GLOBE	XORTX Welcomes New Member to the Board of Directors
4/01/2024	08:00	GLOBE	Aquestive Therapeutics Strengthens Board of Directors with..
3/27/2024	06:57	IHMARKETNEWS	U.S. Stock Index Futures Point to a Rebound, Oil See..
2/14/2024	14:14	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/02/2024	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/02/2024	16:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/02/2024	16:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/02/2024	16:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/02/2024	16:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/29/2024	06:31	EDGAR2	Form 8-K - Current report
1/08/2024	07:00	EDGAR2	Form 8-K - Current report
12/18/2023	06:28	EDGAR2	Form 8-K - Current report
12/15/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
12/06/2023	17:24	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
11/24/2023	16:15	EDGAR2	Form 8-K - Current report
11/20/2023	17:27	EDGAR2	Form SC 13D/A - General statement of acquisition of..
11/15/2023	17:24	EDGAR2	Form S-3 - Registration statement under Securities Act of..
11/15/2023	07:00	EDGAR2	Form 8-K - Current report
11/14/2023	07:00	GLOBE	Gamida Cell Reports Third Quarter 2023 Financial Results and..
11/08/2023	16:05	EDGAR2	Form SC 13D/A - General statement of acquisition of..
10/20/2023	16:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/20/2023	16:01	EDGAR2	Form 8-K - Current report
10/11/2023	07:07	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
10/02/2023	16:01	EDGAR2	Form SC 13D/A - General statement of acquisition of..
9/29/2023	08:41	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
9/27/2023	16:43	EDGAR2	Form 8-K - Current report
9/13/2023	16:01	EDGAR2	Form DEF 14A - Other definitive proxy statements
9/01/2023	16:08	EDGAR2	Form PRE 14A - Other preliminary proxy statements
8/21/2023	17:00	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
8/15/2023	16:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/15/2023	16:11	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/14/2023	16:19	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	07:30	EDGAR2	Form 8-K - Current report
7/11/2023	08:00	BW	Data Published in Transplantation and Cellular Therapy..
7/10/2023	14:00	PRNUS	STAND UP TO CANCER NAMES JULIAN ADAMS, Ph.D., CHIEF SCIENCE..
6/14/2023	16:30	BW	Gamida Cell To Host Investor Day
5/31/2023	16:30	BW	Gamida Cell to Present Corporate Highlights at the Jefferies..
5/31/2023	07:00	BW	Data To Be Presented on Gamida Cell Natural Killer (NK) Cell..
5/22/2023	08:00	BW	Gamida Cell Appoints Terry Coelho as CFO
5/15/2023	16:05	BW	Gamida Cell Reports First Quarter 2023 Financial Results and..
5/11/2023	17:20	BW	Gamida Cell Announces the Date of Its First Quarter 2023..